{
    "organizations": [],
    "uuid": "fc0dcd70ba82ae0d2ee027b1cb7283ee1e7b3986",
    "author": "",
    "url": "https://www.reuters.com/article/brief-radius-health-initiates-phase-3-tr/brief-radius-health-initiates-phase-3-trial-of-abaloparatide-injection-for-male-osteoporosis-idUSASC09UD2",
    "ord_in_thread": 0,
    "title": "BRIEF-Radius Health Initiates Phase 3 Trial Of Abaloparatide Injection For Male Osteoporosis",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 30, 2018 / 6:35 PM / Updated an hour ago BRIEF-Radius Health Initiates Phase 3 Trial Of Abaloparatide Injection For Male Osteoporosis Reuters Staff 1 Min Read \nMarch 30 (Reuters) - Radius Health Inc: \n* RADIUS HEALTH INITIATES PHASE 3 CLINICAL TRIAL OF ABALOPARATIDE INJECTION FOR THE TREATMENT OF MALE OSTEOPOROSIS Source text for Eikon: Further company coverage:",
    "published": "2018-03-30T21:34:00.000+03:00",
    "crawled": "2018-03-30T21:47:47.094+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "pm",
        "updated",
        "hour",
        "ago",
        "health",
        "initiate",
        "phase",
        "trial",
        "abaloparatide",
        "injection",
        "male",
        "osteoporosis",
        "reuters",
        "staff",
        "min",
        "read",
        "march",
        "reuters",
        "radius",
        "health",
        "inc",
        "radius",
        "health",
        "initiate",
        "phase",
        "clinical",
        "trial",
        "abaloparatide",
        "injection",
        "treatment",
        "male",
        "osteoporosis",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}